Trials / Active Not Recruiting
Active Not RecruitingNCT06409494
Clinical Trial to Evaluate EuHZV in Healthy Adults Aged 50 to 69 Years
A PhaseⅠ, Randomized, Observer-blinded, Active Comparator, First-in-human Clinical Trial to Evaluate Safety and Tolerability of Herpes Zoster Vaccine EuHZV in Healthy Adults Aged 50 to 69 Years
- Status
- Active Not Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 72 (actual)
- Sponsor
- EuBiologics Co.,Ltd · Industry
- Sex
- All
- Age
- 50 Years – 69 Years
- Healthy volunteers
- Accepted
Summary
Phase 1 clinical trial to evaluate the safety of HZV-1 and HZV-2 vaccines in healthy adults aged 50 to 69 years who have voluntarily given written consent to participate in this study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | EuHZV | Drug(injection) |
| BIOLOGICAL | Shingrix | Drug(injection) |
Timeline
- Start date
- 2024-07-15
- Primary completion
- 2025-07-31
- Completion
- 2026-05-31
- First posted
- 2024-05-10
- Last updated
- 2025-06-17
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06409494. Inclusion in this directory is not an endorsement.